Andrew M. Schaefer

7.9k total citations · 1 hit paper
64 papers, 4.2k citations indexed

About

Andrew M. Schaefer is a scholar working on Molecular Biology, Clinical Biochemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Andrew M. Schaefer has authored 64 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 46 papers in Clinical Biochemistry and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Andrew M. Schaefer's work include Mitochondrial Function and Pathology (57 papers), Metabolism and Genetic Disorders (46 papers) and ATP Synthase and ATPases Research (28 papers). Andrew M. Schaefer is often cited by papers focused on Mitochondrial Function and Pathology (57 papers), Metabolism and Genetic Disorders (46 papers) and ATP Synthase and ATPases Research (28 papers). Andrew M. Schaefer collaborates with scholars based in United Kingdom, United States and Italy. Andrew M. Schaefer's co-authors include Douglass M. Turnbull, Robert W. Taylor, Robert McFarland, Patrick F. Chinnery, Emma L. Blakely, Gráinne S. Gorman, Yi Shiau Ng, Charlotte L. Alston, Langping He and Catherine Feeney and has published in prestigious journals such as Brain, The Journal of Clinical Endocrinology & Metabolism and Neurology.

In The Last Decade

Andrew M. Schaefer

64 papers receiving 4.2k citations

Hit Papers

Prevalence of nuclear and mitochondrial DNA mutations rel... 2015 2026 2018 2022 2015 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew M. Schaefer United Kingdom 32 3.7k 2.3k 520 316 314 64 4.2k
Emma L. Blakely United Kingdom 38 4.8k 1.3× 2.6k 1.1× 587 1.1× 467 1.5× 379 1.2× 100 5.3k
Charlotte L. Alston United Kingdom 32 2.9k 0.8× 1.7k 0.7× 296 0.6× 394 1.2× 209 0.7× 71 3.3k
Angela Pyle United Kingdom 36 2.6k 0.7× 881 0.4× 699 1.3× 350 1.1× 322 1.0× 90 3.4k
Gavin Hudson United Kingdom 37 3.3k 0.9× 1.4k 0.6× 555 1.1× 359 1.1× 451 1.4× 81 4.5k
Marcus Deschauer Germany 31 1.8k 0.5× 756 0.3× 477 0.9× 218 0.7× 665 2.1× 139 3.0k
Marcela Votruba United Kingdom 30 3.3k 0.9× 816 0.4× 438 0.8× 96 0.3× 320 1.0× 85 4.0k
Yu-ichi Goto Japan 21 1.6k 0.4× 576 0.3× 184 0.4× 276 0.9× 312 1.0× 39 2.1k
A. Prelle Italy 38 2.6k 0.7× 792 0.3× 709 1.4× 212 0.7× 683 2.2× 112 4.7k
Philip G. Griffiths United Kingdom 26 2.4k 0.7× 745 0.3× 308 0.6× 96 0.3× 136 0.4× 55 3.2k
Michaela Jaksch Germany 24 1.5k 0.4× 768 0.3× 185 0.4× 160 0.5× 192 0.6× 40 1.9k

Countries citing papers authored by Andrew M. Schaefer

Since Specialization
Citations

This map shows the geographic impact of Andrew M. Schaefer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew M. Schaefer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew M. Schaefer more than expected).

Fields of papers citing papers by Andrew M. Schaefer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew M. Schaefer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew M. Schaefer. The network helps show where Andrew M. Schaefer may publish in the future.

Co-authorship network of co-authors of Andrew M. Schaefer

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew M. Schaefer. A scholar is included among the top collaborators of Andrew M. Schaefer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew M. Schaefer. Andrew M. Schaefer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnsen, R., Mark R. Davis, U. Moore, et al.. (2022). Identification of a novel heterozygous DYSF variant in a large family with a dominantly‐inherited dysferlinopathy. Neuropathology and Applied Neurobiology. 48(7). e12846–e12846. 8 indexed citations
2.
Farrugia, Maria Elena, Sila Hopton, Gavin Falkous, et al.. (2021). A novel MT-CO2 variant causing cerebellar ataxia and neuropathy: The role of muscle biopsy in diagnosis and defining pathogenicity. Neuromuscular Disorders. 31(11). 1186–1193. 5 indexed citations
4.
Ng, Yi Shiau, Kyle Thompson, Sila Hopton, et al.. (2020). Novel MT-ND Gene Variants Causing Adult-Onset Mitochondrial Disease and Isolated Complex I Deficiency. Frontiers in Genetics. 11. 24–24. 16 indexed citations
5.
Sommerville, Ewen W., Ilaria Dalla Rosa, Masha M. Rosenberg, et al.. (2019). Identification of a novel heterozygous guanosine monophosphate reductase ( GMPR ) variant in a patient with a late‐onset disorder of mitochondrial DNA maintenance. Clinical Genetics. 97(2). 276–286. 7 indexed citations
6.
Vincent, Amy E., Yi Shiau Ng, Kathryn White, et al.. (2016). The Spectrum of Mitochondrial Ultrastructural Defects in Mitochondrial Myopathy. Scientific Reports. 6(1). 30610–30610. 169 indexed citations
7.
Newman, Jane, Brook Galna, Djordje G. Jakovljević, et al.. (2015). Preliminary Evaluation of Clinician Rated Outcome Measures in Mitochondrial Disease. Journal of Neuromuscular Diseases. 2(2). 151–155. 6 indexed citations
8.
Ng, Yi Shiau, Gráinne S. Gorman, Victoria Nesbitt, et al.. (2015). Phenotypes and Genotypes of Mitochondrial Disease- Findings from A National Mitochondrial Disease Cohort (P2.061). Neurology. 84(14_supplement). 1 indexed citations
9.
Yu‐Wai‐Man, Patrick, Victoria Nesbitt, Philip G. Griffiths, et al.. (2014). A national epidemiological study of chronic progressive external ophthalmoplegia in the United Kingdom - molecular genetic features and neurological burden. Investigative Ophthalmology & Visual Science. 55(13). 5109–5109. 4 indexed citations
10.
Hall, Andrew M., Annalisa Vilasi, Isabel García‐Pérez, et al.. (2014). The urinary proteome and metabonome differ from normal in adults with mitochondrial disease. Kidney International. 87(3). 610–622. 43 indexed citations
11.
Galna, Brook, Jane Newman, Djordje G. Jakovljević, et al.. (2013). Discrete gait characteristics are associated with m.3243A>G and m.8344A>G variants of mitochondrial disease and its pathological consequences. Journal of Neurology. 261(1). 73–82. 8 indexed citations
12.
Cope, Thomas, Robert McFarland, & Andrew M. Schaefer. (2011). Rapid-onset, linezolid-induced lactic acidosis in MELAS. Mitochondrion. 11(6). 992–993. 16 indexed citations
13.
Murphy, Jane, Emma L. Blakely, Andrew M. Schaefer, et al.. (2008). Resistance training in patients with single, large-scale deletions of mitochondrial DNA. Brain. 131(11). 2832–2840. 133 indexed citations
14.
Hudson, Gavin, Andrew M. Schaefer, Robert W. Taylor, et al.. (2007). Mutation of the Linker Region of the Polymerase γ-1 (POLG1Gene Associated With Progressive External Ophthalmoplegia and Parkinsonism. Archives of Neurology. 64(4). 553–553. 66 indexed citations
15.
Hudson, Gavin, Patrizia Amati‐Bonneau, Emma L. Blakely, et al.. (2007). Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain. 131(2). 329–337. 304 indexed citations
16.
Taivassalo, Tanja, Justin L. Gardner, Robert W. Taylor, et al.. (2006). Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions. Brain. 129(12). 3391–3401. 146 indexed citations
17.
Schaefer, Andrew M., Joanna L. Elson, Éva Morava, et al.. (2006). A scale to monitor progression and treatment of mitochondrial disease in children. Neuromuscular Disorders. 16(12). 814–820. 50 indexed citations
18.
Schaefer, Andrew M., Emma L. Blakely, Philip G. Griffiths, Douglass M. Turnbull, & Robert W. Taylor. (2005). Ophthalmoplegia due to mitochondrial DNA disease: The need for genetic diagnosis. Muscle & Nerve. 32(1). 104–107. 16 indexed citations
19.
Schaefer, Andrew M., Emma L. Blakely, Robert McFarland, et al.. (2004). Noninvasive diagnosis of the 3243A>G mitochondrial DNA mutation using urinary epithelial cells. European Journal of Human Genetics. 12(9). 778–781. 70 indexed citations
20.
Taylor, Robert W., Andrew M. Schaefer, Robert McFarland, Paul Maddison, & Douglass M. Turnbull. (2002). A novel mitochondrial DNA tRNAIle (A4267G) mutation in a sporadic patient with mitochondrial myopathy. Neuromuscular Disorders. 12(7-8). 659–664. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026